TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Glycorex Transplantation AB (publ)
Closing information (x1000 SEK)
Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Turnover | 36,116 | 28,202 | 27,000 |
Financial expenses | 247 | 402 | 339 |
Earnings before taxes | -8,520 | -12,241 | -8,050 |
EBITDA | 248 | -3,349 | 106 |
Total assets | 96,077 | 101,799 | 112,695 |
Current assets | 45,440 | 50,557 | 57,943 |
Current liabilities | 15,822 | 13,521 | 11,381 |
Equity capital | 74,363 | 82,953 | 95,201 |
- share capital | 3,692 | 3,692 | 3,492 |
Employees (average) | 22 | 24 | 22 |
Financial ratios
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Solvency | 77.4% | 81.5% | 84.5% |
Turnover per employee | 1,642 | 1,175 | 1,227 |
Profit as a percentage of turnover | -23.6% | -43.4% | -29.8% |
Return on assets (ROA) | -8.6% | -11.6% | -6.8% |
Current ratio | 287.2% | 373.9% | 509.1% |
Return on equity (ROE) | -11.5% | -14.8% | -8.5% |
Change turnover | 7,914 | 1,202 | -9,105 |
Change turnover % | 28% | 4% | -25% |
Chg. No. of employees | -2 | 2 | 1 |
Chg. No. of employees % | -8% | 9% | 5% |
Total value of public sale
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.